Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)

The present innovative treatment of PACC with peritoneal metastases used laparotomy to determine the extent of peritoneal metastases, peritonectomy to attempt to completely remove the tumor, HIPEC for intraoperative hyperthermic-chemotherapy, and the HDRA to determine the most effective drug for adjuvant chemotherapy. These procedures can be individualized for each patient's cancer, and the HDRA is most critical for individualization.

Authors

Institutions

Publication Details

Journal
Cancer Diagnosis & Prognosis
Published
2025-05-03
DOI
https://doi.org/10.21873/cdp.10440
Citations
1
Primary Topic
Intraperitoneal and Appendiceal Malignancies
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)

Hiroaki Kimura, Hiroyuki Tsuchiya, Byung Mo Kang, Takashi Higuchi et al.
1 citations
Cancer Diagnosis & Prognosis
Intraperitoneal and Appendiceal Malignancies
2.01
article

Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)

Hiroaki Kimura, Hiroyuki Tsuchiya, Byung Mo Kang, Takashi Higuchi, Yohei Asano, Robert M. Hoffman, Yutaka Yonemura, Shinji Miwa, KOHEI MIZUTA, Satoru Demura, Norio Yamamoto, CHIHIRO HOZUMI, Kentaro Igarashi, Sei Morinaga, Jin-Soo Kim, Katsuhiro Hayashi
article en
1 citations

Abstract

The present innovative treatment of PACC with peritoneal metastases used laparotomy to determine the extent of peritoneal metastases, peritonectomy to attempt to completely remove the tumor, HIPEC for intraoperative hyperthermic-chemotherapy, and the HDRA to determine the most effective drug for adjuvant chemotherapy. These procedures can be individualized for each patient's cancer, and the HDRA is most critical for individualization.

Cancer Diagnosis & PrognosisVol. 5(3)
Kanazawa University (JP), University of California San Diego (US), AntiCancer (United States) (US)
Good health and well-being
Openalex Percentile: Top 16%
Intraperitoneal and Appendiceal Malignancies
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA) — Hiroaki Kimura, Hiroyuki Tsuchiya, et al. · Cancer Diagnosis & Prognosis (2025) | TGRS Research Map | TGRS